注册并分享邀请链接,可获得视频播放与邀请奖励。

Forbes
@Forbes
Sign up now for Forbes' free daily newsletter for unmatched insights and exclusive reporting:
加入 November 2009
4.6K 正在关注    20.3M 粉丝
Shares of biopharmaceutical company Kodiak Sciences Inc. were up more than 150% in the hour after the opening bell Monday morning after promising late-stage trials for a pair of experimental eye drugs that could be the firm’s first products to ever go to market. Read more:
显示更多